ACMG Talk Spells Out Details of Medical Exome Project | GenomeWeb
Home » ACMG Talk Spells Out Details of Medical Exome Project

ACMG Talk Spells Out Details of Medical Exome Project

Mar 27, 2014
|
Andrea Anderson

NASHVILLE, Tenn. (GenomeWeb News) – Researchers from the Children's Hospital of Philadelphia, Harvard University, Massachusetts General Hospital, and Emory University School of Medicine provided additional details about their efforts to annotate and target the exome for clinical applications at the American College of Medical Genetics and Genomics annual meeting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jul 12, 2016

FDA Plans to Use Public Genetic Variant Databases for NGS Test Regulation But Not Many May Qualify

Premium
May 02, 2016

Genomic Variant Data Sharing Gains Support; Collaboration Seen as Key to Interpretation Challenge

Premium
Apr 13, 2016

Emory's New RNA-seq Test for Neuromuscular Disorders Promises to Help Resolve Unknown Variants

Premium
Jun 01, 2016

BRCA Data Sharing Effort Announces More Than 6K Variants, Reclassification of Hundreds of VUS

Mar 11, 2016

Emory Researcher Describes Search for Multigenic Forms of Muscular Dystrophy At ACMG

Jun 30, 2016

FDA Making Progress on NGS Panels Draft Guidance

Premium

The Scan

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

Choice Against Testing

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

Call for Gene Editing Oversight

The Japan Times says regulations are needed to oversee human genome-editing research.

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

What's Popular?

In Clinical Sequencing

  1. Sequencing.com Hopes to Shepherd Growing Market of DIY Genomics Tools

    Premium

  2. Investigators Weigh Nitty Gritty of Sequencing Costs, Question $1,000 Genome

    Premium

  3. FDA Engages Lab, Dx Players by Proposing NGS Regulatory Standards Come From Community

    Premium

  4. UK Team Demonstrates MinIon for UTI Dx, Plans to Develop Sepsis and Respiratory Infection Tests

    Premium

  5. Cancer Gene Panels Could Help to Identify Patients for Immunotherapy, Studies Suggest

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.